BACKGROUND: Taurine is an antioxidant that is abundant in some common energy drinks. Here we hypothesized that the antioxidant activity of taurine in red blood cells (RBCs) could be leveraged to counteract storage-induced oxidant stress. STUDY DESIGN AND METHODS: Metabolomics analyses were performed on plasma and RBCs from healthy volunteers (n = 4) at baseline and after consumption of a whole can of a common, taurine-rich (1000 mg/serving) energy drink. Reductionistic studies were also performed by incubating human RBCs with taurine ex vivo (unlabeled or 13 C15 N-labeled) at increasing doses (0, 100, 500, and 1000 μmol/L) at 37°C for up to 16 hours, with and without oxidant stress challenge with hydrogen peroxide (0.1% or 0.5%). Finally, we stored human and murine RBCs under blood bank conditions in additives supplemented with 500 μmol/L taurine, before metabolomics and posttransfusion recovery studies. RESULTS: Consumption of energy drinks increased plasma and RBC levels of taurine, which was paralleled by increases in glycolysis and glutathione (GSH) metabolism in the RBC. These observations were recapitulated ex vivo after incubation with taurine and hydrogen peroxide. Taurine levels in the RBCs from the REDS-III RBC-Omics donor biobank were directly proportional to the total levels of GSH and glutathionylated metabolites and inversely correlated to oxidative hemolysis measurements. Storage of human RBCs in the presence of taurine improved energy and redox markers of storage quality and increased posttransfusion recoveries in FVB mice. CONCLUSION: Taurine modulates RBC antioxidant metabolism in vivo and ex vivo, an observation of potential relevance to transfusion medicine.
BACKGROUND:Taurine is an antioxidant that is abundant in some common energy drinks. Here we hypothesized that the antioxidant activity of taurine in red blood cells (RBCs) could be leveraged to counteract storage-induced oxidant stress. STUDY DESIGN AND METHODS: Metabolomics analyses were performed on plasma and RBCs from healthy volunteers (n = 4) at baseline and after consumption of a whole can of a common, taurine-rich (1000 mg/serving) energy drink. Reductionistic studies were also performed by incubating human RBCs with taurine ex vivo (unlabeled or 13 C15 N-labeled) at increasing doses (0, 100, 500, and 1000 μmol/L) at 37°C for up to 16 hours, with and without oxidant stress challenge with hydrogen peroxide (0.1% or 0.5%). Finally, we stored human and murine RBCs under blood bank conditions in additives supplemented with 500 μmol/L taurine, before metabolomics and posttransfusion recovery studies. RESULTS: Consumption of energy drinks increased plasma and RBC levels of taurine, which was paralleled by increases in glycolysis and glutathione (GSH) metabolism in the RBC. These observations were recapitulated ex vivo after incubation with taurine and hydrogen peroxide. Taurine levels in the RBCs from the REDS-III RBC-Omics donor biobank were directly proportional to the total levels of GSH and glutathionylated metabolites and inversely correlated to oxidative hemolysis measurements. Storage of human RBCs in the presence of taurineimproved energy and redox markers of storage quality and increased posttransfusion recoveries in FVB mice. CONCLUSION:Taurine modulates RBC antioxidant metabolism in vivo and ex vivo, an observation of potential relevance to transfusion medicine.
Authors: Richard O Francis; Sonia Mahajan; Francesca Rapido; Francesca La Carpia; Mark Soffing; Chaitanya Divgi; Randy Yeh; Akiva Mintz; Lenhurst Leslie; Irina Agrest; Matthew S Karafin; Yelena Ginzburg; Beth H Shaz; Steven L Spitalnik; Joseph Schwartz; Tiffany Thomas; Xiaoyun Fu; Pascal Amireault; Pierre Buffet; James C Zimring; Angelo D'Alessandro; Eldad A Hod Journal: Transfusion Date: 2019-04-19 Impact factor: 3.157
Authors: Isaac A Adedara; Temini Jesu D Ojuade; Bolanle F Olabiyi; Umar F Idris; Esther M Onibiyo; Olufunke F Ajeigbe; Ebenezer O Farombi Journal: Biol Trace Elem Res Date: 2016-06-22 Impact factor: 3.738
Authors: Travis Nemkov; Kaiqi Sun; Julie A Reisz; Anren Song; Tatsuro Yoshida; Andrew Dunham; Matthew J Wither; Richard O Francis; Robert C Roach; Monika Dzieciatkowska; Stephen C Rogers; Allan Doctor; Anastasios Kriebardis; Marianna Antonelou; Issidora Papassideri; Carolyn T Young; Tiffany A Thomas; Kirk C Hansen; Steven L Spitalnik; Yang Xia; James C Zimring; Eldad A Hod; Angelo D'Alessandro Journal: Haematologica Date: 2017-10-27 Impact factor: 9.941
Authors: Tiffany Thomas; Davide Stefanoni; Julie A Reisz; Travis Nemkov; Lorenzo Bertolone; Richard O Francis; Krystalyn E Hudson; James C Zimring; Kirk C Hansen; Eldad A Hod; Steven L Spitalnik; Angelo D'Alessandro Journal: JCI Insight Date: 2020-07-23
Authors: Angelo D'Alessandro; Xiaoyun Fu; Julie A Reisz; Tamir Kanias; Grier P Page; Mars Stone; Steve Kleinman; James C Zimring; Michael Busch Journal: Transfusion Date: 2020-05-11 Impact factor: 3.157
Authors: Tiffany Thomas; Francesca Cendali; Xiaoyun Fu; Fabia Gamboni; Evan J Morrison; Jonathan Beirne; Travis Nemkov; Marianna H Antonelou; Anastasios Kriebardis; Ian Welsby; Ariel Hay; Karolina H Dziewulska; Michael P Busch; Steven Kleinman; Paul W Buehler; Steven L Spitalnik; James C Zimring; Angelo D'Alessandro Journal: Transfusion Date: 2021-04-26 Impact factor: 3.337
Authors: Travis Nemkov; Davide Stefanoni; Aarash Bordbar; Aaron Issaian; Bernhard O Palsson; Larry J Dumont; Ariel Hay; Anren Song; Yang Xia; Jasmina S Redzic; Elan Z Eisenmesser; James C Zimring; Steve Kleinman; Kirk C Hansen; Michael P Busch; Angelo D'Alessandro Journal: JCI Insight Date: 2021-02-08
Authors: Tiffany Thomas; Davide Stefanoni; Monika Dzieciatkowska; Aaron Issaian; Travis Nemkov; Ryan C Hill; Richard O Francis; Krystalyn E Hudson; Paul W Buehler; James C Zimring; Eldad A Hod; Kirk C Hansen; Steven L Spitalnik; Angelo D'Alessandro Journal: J Proteome Res Date: 2020-10-26 Impact factor: 4.466